Symptoms, SARS-CoV-2 Antibodies, and Neutralization Capacity in a Cross Sectional-Population of German Children

被引:8
|
作者
Laub, Otto [1 ]
Leipold, Georg [2 ]
Toncheva, Antoaneta A. [3 ]
Peterhoff, David [4 ,5 ]
Einhauser, Sebastian [4 ]
Neckermann, Patrick [4 ]
Borchers, Natascha [3 ]
Santos-Valente, Elisangela [3 ]
Kheiroddin, Parastoo [3 ]
Buntrock-Doepke, Heike [3 ,6 ]
Laub, Sarah [1 ]
Schoeberl, Patricia [3 ,6 ]
Schweiger-Kabesch, Andrea [3 ]
Ewald, Dominik [7 ]
Horn, Michael [8 ]
Niggel, Jakob [9 ]
Ambrosch, Andreas [10 ]
Ueberla, Klaus [11 ,12 ]
Gerling, Stephan [3 ]
Brandstetter, Susanne [3 ,6 ]
Wagner, Ralf [4 ,5 ]
Kabesch, Michael [3 ,6 ]
机构
[1] Pediat Off Laub, Rosenheim, Germany
[2] Pediat Off Dr Leipold, Regensburg, Germany
[3] Univ Regensburg, Hosp St Hedwig Order St John, Univ Childrens Hosp Regensburg KUNO, Regensburg, Germany
[4] Univ Regensburg, Inst Med Microbiol & Hyg, Mol Microbiol Virol, Regensburg, Germany
[5] Univ Hosp, Inst Clin Microbiol & Hyg, Regensburg, Germany
[6] Hosp St Hedwig Order St John, Res & Dev Campus Regensburg WECARE, Regensburg, Germany
[7] Pediat Off Dr Heuschmann & Dr Ewald, Regenstauf, Germany
[8] Pediat Off Dr Horn, Schonau, Germany
[9] Maganamed Ltd, Regensburg, Germany
[10] Hosp Order St John, Inst Lab Med Microbiol & Hyg, Regensburg, Germany
[11] FAU Erlangen Nuremberg, Inst Clin & Mol Virol, Erlangen, Germany
[12] Univ Klinikum Erlangen, Erlangen, Germany
来源
FRONTIERS IN PEDIATRICS | 2021年 / 9卷
关键词
antibody; neutralizing; COVID-19; SARS-CoV-2; children;
D O I
10.3389/fped.2021.678937
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Background: Children and youth are affected rather mildly in the acute phase of COVID-19 and thus, SARS-CoV-2 infection infection may easily be overlooked. In the light of current discussions on the vaccinations of children it seems necessary to better identify children who are immune against SARS-CoV-2 due to a previous infection and to better understand COVID-19 related immune reactions in children. Methods: In a cross-sectional design, children aged 1-17 were recruited through primary care pediatricians for the study (a) randomly, if they had an appointment for a regular health check-up or (b) if parents and children volunteered and actively wanted to participate in the study. Symptoms were recorded and two antibody tests were performed in parallel directed against S (in house test) and N (Roche Elecsys) viral proteins. In children with antibody response in either test, neutralization activity was determined. Results: We identified antibodies against SARS-CoV-2 in 162 of 2,832 eligible children (5.7%) between end of May and end of July 2020 in three, in part strongly affected regions of Bavaria in the first wave of the pandemic. Approximately 60% of antibody positive children (n = 97) showed high levels (>97th percentile) of antibodies against N-protein, and for the S-protein, similar results were found. Sufficient neutralizing activity was detected for only 135 antibody positive children (86%), irrespective of age and sex. Initial COVID-19 symptoms were unspecific in children except for the loss of smell and taste and unrelated to antibody responses or neutralization capacity. Approximately 30% of PCR positive children did not show seroconversion in our small subsample in which PCR tests were performed. Conclusions: Symptoms of SARS-CoV-2 infections are unspecific in children and antibody responses show a dichotomous structure with strong responses in many and no detectable antibodies in PCR positive children and missing neutralization activity in a relevant proportion of the young population.
引用
收藏
页数:9
相关论文
共 50 条
  • [31] Advances in Neutralization Assays for SARS-CoV-2
    Lu, Yuying
    Wang, Jin
    Li, Qianlin
    Hu, Huan
    Lu, Jiahai
    Chen, Zeliang
    SCANDINAVIAN JOURNAL OF IMMUNOLOGY, 2021, 94 (03)
  • [32] The dynamics of antibodies to SARS-CoV-2 in a case of SARS-CoV-2 infection
    Xia, Yong
    Hong, Honghai
    Feng, Yao
    Liu, Meiling
    Pan, Xingfei
    Chen, Dexiong
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2020, 96 : 359 - 360
  • [33] Detection of SARS-CoV-2 Antibodies: Comparison of Enzyme Immunoassay, Surrogate Neutralization and Virus Neutralization Test
    Vilibic-Cavlek, Tatjana
    Bogdanic, Maja
    Borko, Ema
    Hruskar, Zeljka
    Zilic, Denis
    Ferenc, Thomas
    Tabain, Irena
    Barbic, Ljubo
    Ferenc, Mateja Vujica
    Ferencak, Ivana
    Stevanovic, Vladimir
    ANTIBODIES, 2023, 12 (02)
  • [34] B cell genomics behind cross-neutralization of SARS-CoV-2 variants and SARS-CoV
    Scheid, Johannes F.
    Barnes, Christopher O.
    Eraslan, Basak
    Hudak, Andrew
    Keeffe, Jennifer R.
    Cosimi, Lisa A.
    Brown, Eric M.
    Muecksch, Frauke
    Weisblum, Yiska
    Zhang, Shuting
    Delorey, Toni
    Woolley, Ann E.
    Ghantous, Fadi
    Park, Sung-Moo
    Phillips, Devan
    Tusi, Betsabeh
    Huey-Tubman, Kathryn E.
    Cohen, Alexander A.
    Gnanapragasam, Priyanthi N. P.
    Rzasa, Kara
    Hatziioanno, Theodora
    Durney, Michael A.
    Gu, Xiebin
    Tada, Takuya
    Landau, Nathaniel R.
    West, Anthony P., Jr.
    Rozenblatt-Rosen, Orit
    Seaman, Michael S.
    Baden, Lindsey R.
    Graham, Daniel B.
    Deguine, Jacques
    Bieniasz, Paul D.
    Regev, Aviv
    Hung, Deborah
    Bjorkman, Pamela J.
    Xavier, Ramnik J.
    CELL, 2021, 184 (12) : 3205 - +
  • [35] Executive deficits after SARS-CoV-2 infection: A cross-sectional population study
    Buer, S.
    Hagen, B. I.
    Soraas, A.
    White, R. A.
    Bo, R.
    Ellingjord-Dale, M.
    Istre, M. S.
    Brunvoll, S. H.
    Lerdal, A.
    Landro, N. I.
    Nygaard, A. B.
    Stubberud, J.
    BRAIN BEHAVIOR & IMMUNITY-HEALTH, 2024, 41
  • [36] A retrospective study of SARS-CoV-2 antibodies in children with allergies
    Takaoka, Yuri
    Baba, Yosuke
    Toriumi, Shun
    Ishida, Shoji
    Ebara, Takahiro
    Ohishi, Kenji
    Miyabayashi, Kazuki
    Kojima, Mayuki
    Yamada, Hiromichi
    Yoneyama, Toshiyuki
    Yamazaki, Susumu
    Honjo, Asuka
    Inage, Eisuke
    Shoji, Hiromichi
    Ohtsuka, Yoshikazu
    Shimizu, Toshiaki
    PEDIATRICS INTERNATIONAL, 2023, 65 (01)
  • [37] SARS-CoV-2 Monoclonal Antibodies in Children: Ethical Considerations
    Wolfe, Ian D.
    Patel, Sameer J.
    CLINICAL THERAPEUTICS, 2021, 43 (06) : E157 - E162
  • [38] Cross-neutralization and viral fitness of SARS-CoV-2 Omicron sublineages
    Xia, Hongjie
    Yeung, Jason
    Kalveram, Birte
    Bills, Cody J.
    Chen, John Yun-Chung
    Kurhade, Chaitanya
    Zou, Jing
    Widen, Steven G.
    Mann, Brian R.
    Kondor, Rebecca
    Davis, C. Todd
    Zhou, Bin
    Wentworth, David E.
    Xie, Xuping
    Shi, Pei-Yong
    EMERGING MICROBES & INFECTIONS, 2023, 12 (01)
  • [39] Lessons from low seroprevalence of SARS-CoV-2 antibodies in schoolchildren: A cross-sectional study
    Szepfalusi, Zsolt
    Schmidthaler, Klara
    Sieber, Justyna
    Kopanja, Sonja
    Goetzinger, Florian
    Schoof, Anja
    Hoz, Jakub
    Willinger, Birgit
    Makristathis, Athanasios
    Weseslindtner, Lukas
    Stiasny, Karin
    Bohle, Barbara
    Krotka, Pavla
    Graf, Alexandra
    Frischer, Thomas
    PEDIATRIC ALLERGY AND IMMUNOLOGY, 2021, : 762 - 770
  • [40] Prevalence of SARS-CoV-2 antibodies in hemodialysis patients in Senegal: a multicenter cross-sectional study
    Sidy Mohamed Seck
    Moustapha Mbow
    Yaya Kane
    Mouhamadou Moustapha Cisse
    Gnagna Faye
    Adama Kama
    Moussa Sarr
    Pamela Nitcheu
    Mohamed Dahaba
    Ibrahima Mbemba Diallo
    Mame Selly Diawara
    Lotingo Nehemie Motoula Latou
    Yacine Dia
    Souleymane Mboup
    BMC Nephrology, 22